Gilenya® Demonstrates Consistent Benefits..........

Gilenya, or Fingolimod, is the first approved oral disease modifying drug for MS.

Gilenya® Demonstrates Consistent Benefits..........

Postby MSUK » Mon Mar 25, 2013 11:30 pm

Gilenya® Demonstrates Consistent Benefits In Reduction Of Relapses And Brain Volume Loss In Relapsing-Remitting MS

Data presented at the 65th annual meeting of the American Academy of Neurology (AAN) show Gilenya® (fingolimod), the first and only once-daily oral therapy reimbursed to treat highly active relapsing-remitting multiple sclerosis (RRMS), significantly and consistently reduced the rate of brain volume loss and reduced relapse rates compared to interferon beta-1a IM or placebo.

The new data add to the growing body of evidence for fingolimod regarding its early efficacy benefits and long-term safety profile..........Read More -
User avatar
Family Elder
Posts: 2501
Joined: Wed Oct 14, 2009 2:00 pm


Return to Gilenya


  • Related topics
    Last post

Who is online

Users browsing this forum: No registered users

Contact us | Terms of Service